Portal de investigación
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Aller, R
- Fernandez-Rodriguez, C
- lo Iacono, O
- Banares, R
- Abad, J
- Carrion, JA
- Garcia-Monzon, C
- Caballeria, J
- Rodriguez-Peralvarez, M
- Miranda, JL
- Vilar-Gomez, E
- Crespo, J
- Garcia-Cortes, M
- Reig, M
- Navarro, JM
- Gallego, R
- Genesca, J
- Arias-Loste, MT
- Pareja, MJ
- Albillos, A
- Muntane, J
- Jorquera, F
- Sola, E
- Hernandez-Guerra, M
- Rojo, MA
- Salmeron, J
- Caballeria, L
- Diago, M
- Molina, E
- Bataller, R
- Romero-Gomez, M
Grupos
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the main cause of liver diseases in Spain and the incidence is raising due to the outbreak of type 2 diabetes and obesity. This CPG suggests recommendation about diagnosis, mainly non-invasive biomarkers, and clinical management of this entity. Life-style modifications to achieve weight toss is the main target in the management of NAFLD. Low caloric Mediterranean diet and 200 minutes/week of aerobic exercise are encouraged. In non-responders patients with morbid obesity, bariatric surgery or metabolic endoscopy could be indicated. Pharmacological therapy is indicated in patients with NASH and fibrosis and non-responders to weight loss measures. NAFLD could influence liver transplantation, as a growing indication, the impact of steatosis in the graft viability, de novo NAFLD rate after OLT and a raised cardiovascular risk that modify the management of this entity. The current CPG was the result of the First Spanish NAFLD meeting in Seville. (C) 2018 Elsevier Espana, S.L.U. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0210-5705, 0210-5705
- Tipo:
- Review
- Páginas:
- 328-349
- PubMed:
- 29631866
- Factor de Impacto:
- 0,203 SCImago ℠
- Cuartil:
- Q4 SCImago ℠
Gastroenterologia y Hepatologia ELSEVIER ESPANA SLU
Citas Recibidas en Web of Science: 93
Documentos
- No hay documentos
Filiaciones
Keywords
- Non-alcoholic fatty liver disease; Diagnosis; Treatment; Clinical guidelines; Recommendations; Steatosis; Fibrosis; Cardiovascular risk
Campos de Estudio
Cita
Aller R,Fernandez C,lo Iacono O,Banares R,Abad J,Carrion JA,Garcia C,Caballeria J,Berenguer M,Rodriguez M,Miranda JL,Vilar E,Crespo J,Garcia M,Reig M,Navarro JM,Gallego R,Genesca J,Arias MT,Pareja MJ,Albillos A,Muntane J,Jorquera F,Sola E,Hernandez M,Rojo MA,Salmeron J,Caballeria L,Diago M,Molina E,Bataller R,Romero M. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. Gastroenterol. Hepatol. 2018. 41(5):p. 328-349. IF:1,126. (4).